scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1107406011 |
P356 | DOI | 10.1007/S10461-018-2290-3 |
P698 | PubMed publication ID | 30284653 |
P50 | author | Garrett Prestage | Q41676746 |
David J Templeton | Q45413753 | ||
Rebecca Guy | Q58324757 | ||
P2093 | author name string | Andrew Carr | |
Andrew E Grulich | |||
Mark Bloch | |||
Catriona Ooi | |||
David Templeton | |||
Anna McNulty | |||
Isobel M Poynten | |||
Iryna B Zablotska | |||
Garrett Prestage | |||
Rosalind Foster | |||
Nathan Ryder | |||
Catherine Pell | |||
Andrew E. Grulich | |||
Iryna B. Zablotska | |||
Stefanie J Vaccher | |||
Isobel M. Poynten | |||
Stefanie J. Vaccher | |||
P407 | language of work or name | English | Q1860 |
P921 | main subject | seroconversion | Q2141450 |
P577 | publication date | 2018-10-04 | |
P1433 | published in | AIDS and Behavior | Q15752229 |
P1476 | title | High Adherence to HIV Pre-exposure Prophylaxis and No HIV Seroconversions Despite High Levels of Risk Behaviour and STIs: The Australian Demonstration Study PrELUDE |
Q89613721 | Can gut microbiota of men who have sex with men influence HIV transmission? |
Q92062770 | Facilitating engagement with PrEP and other HIV prevention technologies through practice-based combination prevention |
Q91583474 | Transformation of Australian Community Pharmacies Into Good Clinical Practice Compliant Trial Pharmacies for HIV Pre-Exposure Prophylaxis |
Search more.